# EDGAR Filing Document

**Accession Number:** 0000021076
**File Stem:** 0001206774-26-000338
**Filing Date:** 2026-6
**Character Count:** 33326
**Document Hash:** ed9714936b395525ef3323d8a1e71b85
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001206774-26-000338.hdr.sgml**: 20260625

**ACCESSION NUMBER**: 0001206774-26-000338

**CONFORMED SUBMISSION TYPE**: 11-K

**PUBLIC DOCUMENT COUNT**: 33

**CONFORMED PERIOD OF REPORT**: 20251231

**FILED AS OF DATE**: 20260625

**DATE AS OF CHANGE**: 20260625

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CLOROX CO /DE/
- **CENTRAL INDEX KEY:** 0000021076
- **STANDARD INDUSTRIAL CLASSIFICATION:** SPECIALTY CLEANING, POLISHING AND SANITATION PREPARATIONS [2842]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 310595760
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** 11-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-07151
- **FILM NUMBER:** 261122069

**BUSINESS ADDRESS:**
- **STREET 1:** THE CLOROX COMPANY
- **STREET 2:** 1221 BROADWAY
- **CITY:** OAKLAND
- **STATE:** CA
- **ZIP:** 94612-1888
- **BUSINESS PHONE:** 5102717000

**MAIL ADDRESS:**
- **STREET 1:** P.O. BOX 24305
- **CITY:** OAKLAND
- **STATE:** CA
- **ZIP:** 94612-1305

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, DC 20549**

____________________

**FORM 11-K**

**FOR ANNUAL REPORTS OF EMPLOYEE STOCK**

**PURCHASE, SAVINGS AND SIMILAR PLANS**

**PURSUANT TO SECTION 15(d) OF THE**

**SECURITIES EXCHANGE ACT OF 1934**

(Mark One):

☑ ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2025

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___________________ to ____________________

Commission file number 1-07151

A. Full title of the plan and the address of the plan, if different from that of the issuer named below:

**The Clorox Company 401(k) Plan**

**(formerly The Clorox Company Employee Retirement Investment Plan)**

B. Name of issuer of the securities held pursuant to the plan and the address of its principal executive office:

**The Clorox Company**

**1221 Broadway**

**Oakland, CA 94612-1888**

Report of Independent Registered Public Accounting Firm

Financial Statements and Supplemental Information

**The Clorox Company 401(k) Plan**

As of December 31, 2025 and 2024 and for the

Plan year ended December 31, 2025

The Clorox Company 401(k) Plan

Financial Statements and Supplemental Information

As of December 31, 2025 and 2024

and for the Plan year ended December 31, 2025

Contents

---

| | |
|:---|:---|
| [Report of Independent Registered Public Accounting Firm](#a_001) | [1](#a_001) |
| Audited Financial Statements |  |
| [Statements of Net Assets Available for Benefits](#a_002) | [3](#a_002) |
| [Statement of Changes in Net Assets Available for Benefits](#a_003) | [4](#a_003) |
| [Notes to Financial Statements](#a_004) | [5](#a_004) |
| [Supplemental Information](#a_005) |  |
| [Schedule H, Line 4i – Schedule of Assets (Held at End of Year)](#a_007) | [15](#a_007) |
| Exhibit 23.1 – Consent of Independent Registered Public Accounting Firm | 16 |

---

**Report of Independent Registered Public Accounting Firm**

To the Participants and Employee Benefits Committee of

The Clorox Company 401(k) Plan

**Opinion on the Financial Statements**

We have audited the accompanying statements of net assets available for benefits of The Clorox Company 401(k) Plan (the Plan) as of December 31, 2025 and 2024, the related statement of changes in net assets available for benefits for the year ended December 31, 2025, and the related notes (collectively referred to as the financial statements). In our opinion, the financial statements present fairly, in all material respects, the net assets available for benefits of the Plan as of December 31, 2025 and 2024, and the changes in net assets available for benefits for the year ended December 31, 2025, in conformity with accounting principles generally accepted in the United States of America.

**Basis for Opinion**

These financial statements are the responsibility of the Plan's management. Our responsibility is to express an opinion on the Plan's financial statements based on our audit*s*. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Plan in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit*s* in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Plan is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Plan's internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures to respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit*s* provide a reasonable basis for our opinion.

**Opinion on the Supplemental Information**

The supplemental information included in Schedule H, Line 4(i) – Schedule of Assets (Held at End of Year) as of December 31, 2025, has been subjected to audit procedures performed in conjunction with the audit of the Plan's financial statements. The supplemental information is the responsibility of the Plan's management. Our audit procedures included determining whether the supplemental information reconciles to the financial statements or the underlying accounting and other records, as applicable, and performing procedures to test the completeness and accuracy of the information presented in the supplemental information. In forming our opinion on the supplemental information in the accompanying schedule, we evaluated whether the supplemental information, including its form and content, is presented in conformity with Department of Labor's Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974. In our opinion, the supplemental information in the accompanying schedule is fairly stated, in all material respects, in relation to the financial statements as a whole.

/s/ Baker Tilly US, LLP

 

*Seattle, Washington*

*June 25, 2026*

We have served as the Plan's auditor since 2013.

The Clorox Company 401(k) Plan

Statements of Net Assets Available for Benefits

---

| | | |
|:---|:---|:---|
|  | **As of December 31,** | **As of December 31,** |
|  | **2025** | **2024** |
| **Assets** |  |  |
| Investments, at fair value | $2418912514 | $2227729336 |
| Receivables: |  |  |
| &nbsp;&nbsp;&nbsp;Notes receivable from participants | 19273572 | 19022223 |
| &nbsp;&nbsp;&nbsp;Employer's contributions | 33536352 | 34083168 |
| Total receivables | 52809924 | 53105391 |
| Total assets | 2471722438 | 2280834727 |
| **Liabilities** |  |  |
| Accrued fees | 167678 | 231118 |
| **Net assets available for benefits** | $2471554760 | $2280603609 |

---

*See accompanying notes to the financial statements.*

The Clorox Company 401(k) Plan

Statement of Changes in Net Assets Available for Benefits

For the Plan Year Ended December 31, 2025

---

| | |
|:---|:---|
| **Additions to (deductions from) net assets attributable to:** | |
| Investment and other income: |  |
| &nbsp;&nbsp;&nbsp;Interest income and dividends | $11178607 |
| &nbsp;&nbsp;&nbsp;Net appreciation in fair value of investments | 291108066 |
| Total investment and other income | 302286673 |
| Contributions: |  |
| &nbsp;&nbsp;&nbsp;Employer | 51243591 |
| &nbsp;&nbsp;&nbsp;Participants | 57159902 |
| &nbsp;&nbsp;&nbsp;Rollovers | 7449264 |
| Total contributions | 115852757 |
| Benefits paid to participants | (228543753) |
| Administrative expenses | (1261054) |
| Total benefits paid and administrative expenses | (229804807) |
| **Net increase** | 188334623 |
| **Transfer from another qualified plan** | 2616528 |
| **Net assets available for benefits:** |  |
| &nbsp;&nbsp;&nbsp;Beginning of year | 2280603609 |
| &nbsp;&nbsp;&nbsp;End of year | $2471554760 |

---

*See accompanying notes to the financial statements.*

The Clorox Company 401(k) Plan

Notes to Financial Statements

1. Description of the Plan

The following description of The Clorox Company 401(k) Plan (the "Plan") provides only general information. Participants should refer to the Plan document for a more complete description of the Plan's provisions.

**General**

The Plan is a defined contribution plan covering substantially all employees of The Clorox Company and its affiliated companies that have adopted the Plan ("Participating Company") (collectively referred to as "Company"). The following employees are not covered by the Plan: (i) leased employees (contractors), (ii) nonresident aliens with no United States of America source of income, (iii) employees covered by a collective bargaining agreement, unless such coverage is specified in the written agreement, (iv) employees sent to a Participating Company by an international subsidiary to participate in a training or development program sponsored by the Participating Company, and (v) employees who are residents of Puerto Rico or who perform services for a Participating Company primarily in Puerto Rico and are participants of The Clorox Company Employee Retirement Investment Plan for Puerto Rico. Participants are eligible to participate on the first day of employment with the Company. The Plan is subject to the provisions of the Employee Retirement Income Security Act of 1974, as amended ("ERISA").

The Company maintains a non-leveraged employee stock ownership plan (the "ESOP") within the meaning of Section 4975(e)(7) of the Internal Revenue Code of 1986, as amended (the "Code"). The ESOP is maintained as part of the Plan and is designed to invest in the Company's common stock. If elected, participants can receive dividends paid directly to them in cash. No participant shall be permitted to direct more than 5% of the contributions to be made to the Plan on their behalf in the ESOP fund; and no participant shall be permitted to effect a transfer or exchange from another investment fund into the ESOP fund if the portion of the participant's account invested in the ESOP fund would exceed 5% of their account balance immediately after such transfer or exchange.

The Employee Benefits Committee (the "Committee") administers the Plan. The Vanguard Fiduciary Trust Company and Vanguard Group, Inc. ("Vanguard") are the Plan's trustee and recordkeeper, respectively.

The Clorox Company 401(k) Plan

Notes to Financial Statements (continued)

1. Description of the Plan (continued)

**Contributions**

*Salary Deferral Contributions*

The Plan allows for automatic enrollment at a rate of 6% for newly eligible participants who do not make a salary deferral contribution election, or fail to elect to decline a deferral contribution.

Participants may contribute from 1% to 50% of their covered compensation, on a pre-tax and after-tax basis, as defined in the Plan. Participants also have the option to contribute on a Roth basis. The combined pre-tax, after-tax and Roth contributions cannot exceed the 50% limit. Generally, covered compensation consists of regular pay plus most bonuses, overtime and vacation pay. It does not include, for example, short or long term disability pay, relocation, severance, deferred compensation, stock compensation, or Worker's Compensation pay. Participant contributions are subject to limits specified under the Code.

*Matching Contributions*

Employees not covered by a collective bargaining agreement are eligible to receive a matching contribution of 100% of salary deferral contributions, including pre-tax, after-tax and Roth contributions, up to a maximum of 4% of covered compensation.

Certain participants covered by a collective bargaining agreement are eligible to receive a Company match of 100% of salary deferral contributions, including pre-tax, after-tax and Roth contributions up to 3% of eligible compensation. There were no employees covered by a collective bargaining agreement during the year ended December 31, 2025.

Participants are eligible for the Company matching contribution after completing one year of service. Matching contributions are funded each pay period.

The Clorox Company 401(k) Plan

Notes to Financial Statements (continued)

 

1. Description of the Plan (continued)

*Non-elective Employer Contributions*

Certain participants are also eligible for a non-elective employer contribution. To receive a non-elective employer contribution for a particular Plan year, a participant must have completed at least one year of service prior to December 31 of the Plan year. A participant must also have been an eligible employee sometime during the Plan year and have been employed with the Company on December 31 of the Plan year or have separated from service during the Plan year due to death or certified disability, attainment of age 60 (age 62 for any participant not covered by a collective bargaining agreement and who first becomes a participant on or after July 1, 2011) or attainment of age 55 and 10 years of service. Additionally, certain participants can be deemed eligible at the discretion of the Committee.

The non-elective employer contribution is equal to 6% of covered compensation. The non-elective employer contributions are funded during the quarter subsequent to the Plan year end. See "Vesting" section for more information.

*Rollover Contributions*

Participants may also rollover amounts representing distributions from other qualified defined benefit, individual retirement accounts or defined contribution plans. Subject to Committee discretion, participants may also transfer outstanding loans under a plan sponsored by an entity that was acquired by or merged with the Company.

**Investment Options**

Participants direct the investment of their contributions and the Company contributions into the various investment options offered by the Plan. The Plan offers investments in mutual funds, common collective trust funds, and the Company's common stock. Participants are also allowed to direct their contributions to a self-directed brokerage account which permits investments in additional mutual funds, common stocks, and other investment products.

**Notes Receivable from Participants**

Participants may borrow a minimum of $1,000 from their fund accounts up to a maximum equal to the lesser of $50,000 or 50% of their vested account balance. Loan terms range from one to 5 years, or up to 15 years if loan proceeds are used for the purchase of a primary residence. The loans are secured by the balance in the participant's account and bear interest at a fixed rate (prime plus 1%) determined at the time of the loan. Principal and accrued interest are repaid ratably through payroll deductions or directly to the custodian by the participant.

The Clorox Company 401(k) Plan

Notes to Financial Statements (continued)

1. Description of the Plan (continued)

**Participant Accounts and Forfeitures**

Each participant's account is credited with the participant's contribution and allocations of: (a) Company contributions and (b) Plan earnings. Allocations are based on participants' eligible compensation for the employer match and non-elective employer contribution and investment balances for investment earnings. At the discretion of the Committee, forfeited balances of terminated participants' non-vested accounts may be used to pay the Plan's expenses, to reduce the Company's contributions to the Plan, or to restore accounts of previously terminated participants who subsequently resumed employment with the Company. The amounts of unallocated accounts including forfeitures related to non-vested accounts at December 31, 2025 and 2024 are approximately $2,246,000 and $2,546,000, respectively. Subsequent to year end, the Company used $1,570,000 and $1,750,000 of forfeitures to reduce the non-elective employer contribution for the Plan years ended December 31, 2025 and 2024, respectively.

**Vesting**

Participants are always fully vested in their individual contributions, Company matching contributions, and actual earnings thereon.

The non-elective employer contribution will vest in varying rates over a period of 5 years as follows:

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;**Years of Service** | **Vesting Percentage** |
| &nbsp;&nbsp;&nbsp;&nbsp;1 | 0% |
| &nbsp;&nbsp;&nbsp;&nbsp;2 | 20% |
| &nbsp;&nbsp;&nbsp;&nbsp;3 | 40% |
| &nbsp;&nbsp;&nbsp;&nbsp;4 | 70% |
| &nbsp;&nbsp;&nbsp;&nbsp;5 | 100% |

---

Participants become immediately vested in the non-elective employer contributions upon reaching age 60 (age 62 for participants not covered by a collective bargaining agreement and who first became a participant on or after July 1, 2011) while employed by the Company, at death, or upon permanent disability. In certain cases, the Committee has the authority to accelerate vesting for specific participants.

**Payment of Benefits**

The Plan allows for lump-sum and partial distributions of the vested value of a participant's account at death, upon permanent disability, retirement or upon termination of employment. Hardship and other in-service withdrawals are permitted if certain criteria are met.

The Clorox Company 401(k) Plan

Notes to Financial Statements (continued)

1. Description of the Plan (continued)

**Administrative Expenses**

The Company pays all administrative expenses except for the quarterly recordkeeping fees, certain investment fees and loan fees, which are deducted from the affected participant's account.

**Plan Termination**

Although it has not expressed any intent to do so, the Company has the right under the Plan to discontinue or decrease its contributions at any time and to terminate the Plan subject to the provisions of ERISA. In the event of the Plan's termination, participants will become 100% vested in their accounts.

**Plan Amendment**

The Plan was amended in February 2025 to be the "qualified replacement plan" as defined in the Code for The Clorox Company Pension Plan (the "Pension Plan"), another plan sponsored by the Company. As a result, $2,617,000 of excess plan assets from the Pension Plan were transferred into the Plan in February 2025. This amount was used to fund a portion of the non-elective employer contribution.

2. Summary of Accounting Policies

**Basis of Accounting**

The accompanying financial statements are prepared in accordance with generally accepted accounting principles in the United States of America ("U.S. GAAP").

The Plan's financial statements were evaluated for subsequent events from the date after the financial statement date through June 25, 2026, the date the financial statements were issued.

**Investment Valuation and Income Recognition**

The Plan's investments are stated at fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. See Note 3 for further discussion of fair value measurements.

Purchases and sales of securities are recognized on a trade-date basis. Interest income is recorded on the accrual basis. Dividends are recorded on the ex-dividend date.

The Clorox Company 401(k) Plan

Notes to Financial Statements (continued)

2. Summary of Accounting Policies (continued)

The net appreciation in fair value of investments consists of both the realized gains and losses and unrealized appreciation and depreciation of those investments.

**Notes Receivable from Participants**

Notes receivable from participants are measured at their unpaid principal balance plus any accrued but unpaid interest. Delinquent participant loans are reclassified as distributions based upon the terms of the Plan Document.

**Risk and Uncertainties**

The Plan provides for various participant directed investment options in mutual funds, common stocks, common collective trust funds, and a self-directed brokerage account. Investment securities, in general, are exposed to various risks, such as interest rate, credit, and overall market volatility risk. Due to the level of risk associated with certain investment securities, it is reasonably possible that changes in the values of investment securities will occur in the near term and that such changes could materially affect the amounts reported in the statement of net assets available for benefits and participant account balances.

**Payment of Benefits**

Benefits paid to participants are recognized upon payment.

**Use of Estimates**

The preparation of financial statements in conformity with U.S. GAAP requires the Plan's management to make estimates that affect the amounts reported in the financial statements and accompanying footnotes. Actual results could differ from those estimates.

3. Fair Value Measurements

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (i.e., an exit price). Assets and liabilities measured at fair value are required to be classified and disclosed based on the lowest level of input that is significant to the fair value measurement in one of the following categories:

Level 1 – Quoted market prices in active markets for identical assets or liabilities.

Level 2 – Observable market-based inputs or unobservable inputs that are corroborated by market data.

Level 3 – Unobservable inputs reflecting management's own assumptions.

The Clorox Company 401(k) Plan

Notes to Financial Statements (continued)

3. Fair Value Measurements (continued)

The following is a description of the valuation methodologies used for assets and liabilities measured at fair value:

Mutual funds: Valued at quoted market prices of shares held by the Plan at year-end.

Company's common stock (and other common stocks as part of self-directed brokerage account): Valued at the last reported quoted market sales price at year-end.

Interest-bearing accounts (part of self-directed brokerage account): Valued at cost plus accrued interest, which approximates fair value, at year-end.

Common collective trust funds: Valued using the market approach at a net asset value ("NAV") as a practical expedient determined by the portfolio's sponsor based on the fair value of underlying investments held by the fund, minus its liabilities, and then divided by the number of units outstanding on the last business day of the Plan year. These are not classified in the fair value hierarchy table. The fair values are included in the table to allow reconciliation of the fair value hierarchy to the fair value of investments per the statement of net assets available for benefits.

The methods described above may produce a fair value calculation that may not be indicative of net realizable value or reflective of future fair values. Furthermore, while the Plan believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement at the reporting date.

Certain common collective trust funds may require that within 90 days from withdrawal, money from the funds cannot be invested directly into a competing fund. Certain funds retain the right to reject transactions where market timing activity is detected. Rejection can occur within 90 days, or for multiple infractions, rejection can be temporary or permanent. Generally, completing two 'round trips' within 60 days is considered market timing. A round trip consists of purchase or exchange if followed by or preceded by redemption or exchange out. Others retain discretion to limit the maximum withdrawal as of any date to the greater of $2,000,000 or 5% of the value of the investment.

The Clorox Company 401(k) Plan

Notes to Financial Statements (continued)

3. Fair Value Measurements (continued)

The following table sets forth by level, within the fair value hierarchy, the Plan's assets carried at fair value.

---

| | | |
|:---|:---|:---|
|  | Fair Value as of December 31, 2025 | Fair Value as of December 31, 2025 |
|  | Level 1 | Total |
| Mutual funds | $126304016 | $126304016 |
| Company's common stock | 39035502 | 39035502 |
| Self directed brokerage account | 51524459 | 51524459 |
| Total assets in the fair value hierarchy | $216863977 | $216863977 |
| Common collective trust funds measured at NAV, practical expedient |  | 2202048537 |
| Investments at fair value |  | $2418912514 |

---

---

| | | |
|:---|:---|:---|
|  | Fair Value as of December 31, 2024 | Fair Value as of December 31, 2024 |
|  | Level 1 | Total |
| Mutual funds | $150848146 | $150848146 |
| Company's common stock | 67229998 | 67229998 |
| Self directed brokerage account | 42389887 | 42389887 |
| Total assets in the fair value hierarchy | $260468031 | $260468031 |
| Common collective trust funds measured at NAV, practical expedient |  | 1967261305 |
| Investments at fair value |  | $2227729336 |

---

4. Party-in-Interest Transactions

Transactions in shares of the Company's common stock qualify as party-in-interest transactions under the provisions of ERISA. During the Plan year ended December 31, 2025, the Plan purchased or received approximately $5,406,000 and sold or distributed approximately $8,861,000 of the Company's common stock.

Certain Plan assets are invested in funds managed by the trustee. Consequently, transactions with the trustee qualify as party-in-interest transactions for which a statutory exemption exists.

The Clorox Company 401(k) Plan

Notes to Financial Statements (continued)

5. Income Tax Status

The Plan received a determination letter from the Internal Revenue Service (the "IRS") dated March 8, 2017, stating that the Plan is qualified under Section 401(a) of the Code. Qualification under Section 401(a) of the Code means the related trust is exempt from taxation. Subsequent to this determination by the IRS, the Plan was amended. The Plan's management believes that the Plan is being operated in accordance with the applicable requirements of the Code and therefore believes that the Plan, as amended, is qualified and the related trust is tax-exempt. The Company has indicated that it will take the necessary steps, if any, to maintain the Plan's operations in compliance with the Code.

U.S. GAAP requires plan management to evaluate uncertain tax positions taken by the Plan. The financial statement effects of a tax position are recognized when the position meets certain recognition thresholds or measurement standards defined by U.S. GAAP. The Plan administrator has analyzed the tax positions taken by the Plan, and has concluded that as of December 31, 2025, there are no uncertain positions taken or expected to be taken. The Plan has recognized no interest or penalties related to uncertain tax positions. The Plan may be subjected to routine audits by taxing jurisdictions; however, there are currently no audits in progress for any tax periods.

6. Other Contingencies

On October 23, 2023, the Company and the Committee were served with a class action complaint in the United States District Court for the Northern District of California alleging that the Company and the Committee breached their fiduciary duties to participants of the Plan by utilizing forfeited funds for contributions. The Company believes that it has been managing forfeited funds consistent with legal authority and its policies. On December 13, 2023, the Company filed a motion to dismiss which was granted with leave to amend. On November 12, 2024, Plaintiff filed an amended complaint and on March 3, 2025, the Company and Committee filed its second motion to dismiss. In late March 2025, the second motion to dismiss was denied. In early April 2025, the parties agreed to stay the matter while a companion case is appealed to the 9<sup>th</sup> Circuit. The Company continues to deny the allegations in the amended complaint and is defending itself and the Committee.

Supplemental Information

**The Clorox Company 401(k) Plan EIN: 31-0595760 Plan: 001**

**Schedule H, Line 4i – Schedule of Assets (Held at End of Year)**

**December 31, 2025**

---

| | | | |
|:---|:---|:---|:---|
| **(a)** | **(b)<br> Identity of Issue, Borrower,<br> Lessor, or Similar Party** | **(c)<br> Description of Investment, Including<br> Maturity Date, Rate of Interest,<br> Collateral, Par, or Maturity Value** | **(e)<br> Current Value** |
|  | Eaton Vance Atlanta Capital SMID Cap Fund | Mutual fund | $119030901 |
|  | Northern World Selection Index Fund | Mutual fund | 7273115 |
|  |  |  | 126304016 |
| \* | Vanguard Institutional 500 Index Trust | Common collective trust fund | 405969059 |
|  | J.P. Morgan Chase Bank US Active Core Equity Fund | Common collective trust fund | 206829869 |
| \* | Vanguard Institutional Total Bond Market Index Trust | Common collective trust fund | 155816213 |
| \* | Vanguard Institutional Total International Stock Market Index Trust | Common collective trust fund | 143915488 |
|  | State Street Russell Small Mid Cap Index Securities Lending Series Fund | Common collective trust fund | 128022910 |
|  | Galliard Stable Return Fund | Common collective trust fund | 100354192 |
|  | MFS International Equity | Common collective trust fund | 51398650 |
|  | Prudential Global Investment Management Core Plus Bond Fund | Common collective trust fund | 37885991 |
| \* | Vanguard Target Retirement Income Trust I | Common collective trust fund | 23520976 |
| \* | Vanguard Target Retirement 2020 Trust I | Common collective trust fund | 26873600 |
| \* | Vanguard Target Retirement 2025 Trust I | Common collective trust fund | 91169225 |
| \* | Vanguard Target Retirement 2030 Trust I | Common collective trust fund | 79981899 |
| \* | Vanguard Target Retirement 2035 Trust I | Common collective trust fund | 192101187 |
| \* | Vanguard Target Retirement 2040 Trust I | Common collective trust fund | 104959736 |
| \* | Vanguard Target Retirement 2045 Trust I | Common collective trust fund | 216519254 |
| \* | Vanguard Target Retirement 2050 Trust I | Common collective trust fund | 96462333 |
| \* | Vanguard Target Retirement 2055 Trust I | Common collective trust fund | 85245440 |
| \* | Vanguard Target Retirement 2060 Trust I | Common collective trust fund | 40375245 |
| \* | Vanguard Target Retirement 2065 Trust I | Common collective trust fund | 12901636 |
| \* | Vanguard Target Retirement 2070 Trust I | Common collective trust fund | 1745634 |
|  |  |  | 2202048537 |
| \* | The Clorox Company Common Stock | Common stock | 39035502 |
| \*\* | Vanguard Brokerage Option | Self-directed brokerage account | 51524459 |
| \* | Participant loans | Interest rates ranging from 4.25% to 9.5% and with maturities through July 2040 | 19273572 |
|  | Total investments |  | $2438186086 |

---

\* Indicates a party-in-interest to the Plan.

\*\* May include party-in-interest investments

Note: Column (d), cost, has been omitted, as all investments are participant-directed.

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the trustees (or other persons who administer the employee benefit plan) have duly caused this annual report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | |
|:---|:---|
|  | THE CLOROX COMPANY 401 (K) PLAN (FORMERLY THE CLOROX COMPANY EMPLOYEE RETIREMENT INVESTMENT PLAN) |
| Date: June 25, 2026 | /s/ Angela Hilt |
|  | Angela Hilt |
|  | Executive Vice President – Chief Legal and External Affairs Officer and Corporate Secretary |

---

Index to Exhibits

<u>Exhibit No.</u>   <u>Description</u> <br>[23.1](clx4653651-ex231.htm) [Consent of Baker Tilly US, LLP](clx4653651-ex231.htm)

## Exhibit 23.1

Exhibit 23.1

**Consent of Independent Registered Public Accounting Firm**

We consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-41131 – Post Effective Amendments No. 1 and 2) of The Clorox Company of our report dated June 25, 2026, relating to the financial statements and supplemental information of The Clorox Company 401(k) Plan (the Plan) appearing in this Annual Report on Form 11-K of the Plan for the year ended December 31, 2025.

/s/ Baker Tilly US, LLP

Seattle, Washington

June 25, 2026